Johnson & Johnson (NYSE: JNJ) announced a total of $19.7B in sales and 10.3% growth in worldwide sales in the Q3 of 2017 that includes growth reported in all three of its sectors: Consumer, Medical Devices and Pharmaceuticals.
To learn more about Johnson & Johnson (NYSE: JNJ) and to track its progress please visit the Vista Partners Company Dedicated JNJ Coverage Page.
What You Need to Know About Johnson & Johnson’s 2017 Third-Quarter Earnings
Learn how the company’s consumer, pharmaceutical and medical devices businesses performed in this recap of the 2017 third-quarter earnings report. ..